Novartis’ Results Could Be a Good Looking Glass into Successful Commercial Future for Amarin
Amarin Corporation plc (NASDAQ:AMRN) announced financial results for the three and six months ended June 30, 2017, and provided an update on company operations. …
Cantor analyst Louise Chen was out pounding the table on shares of Amarin Corporation plc (ADR) (NASDAQ:AMRN), assuming an Overweight rating and price …
Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced two EPA-related data presentations unveiled this week at the American Diabetes Association® 77th Scientific Sessions in San …
Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced financial results for the quarter and year ended December 31, 2016, and provided an update on company …
As REDUCE-IT continues to track to expected read-outs in early 2018, H.C.
Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced that it and its wholly owned subsidiary, Corsicanto II Designated Activity Company, have entered into separate, privately …
In a research report published Tuesday, Cantor analyst Chiara Russo reiterated an Overweight rating on shares of Amarin Corporation plc (ADR) (NASDAQ:AMRN), with …
Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced an oral presentation at the American Heart Association Scientific Sessions 2016, New Orleans on November 14, 2016that …
Amarin Corporation plc (ADR) (NASDAQ:AMRN) announced financial results for the three and nine months ended September 30, 2016, and provided an update on company …
